Eicosapentaenoic acid/γ-Linolenic acid

二十碳五烯酸/γ-亚麻酸

Report date: 2023/04/23 15:22:49

Base Information

Drug NameEicosapentaenoic acid/γ-Linolenic acid
Drug Alias Nameγ-Linolenic acid/Eicosapentaenoic acidγ-亚麻酸/二十碳五烯酸AmeloradSO-5407EF-27 +[6
ClassificationSmall molecules
Mechanisms of ActionThromboxane A2 synthase inhibitors
TargetsThromboxane A2 synthase
Therapy Area/IndicationsRadiation Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Eicosapentaenoic acid
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesScotia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScotia
Active IndicationsN/A
Inactive IndicationsRadiation Injuries

Other Information

ATC CodeN/A
Related LinksN/A